lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

The Effectiveness of COVID-19 Vaccination in a Regional Population

14 Pages Posted: 3 Jan 2023

See all articles by Nicolas Smoll

Nicolas Smoll

Central Queensland Hospital and Health Service - Central Queensland Public Health Unit

Mahmudul Al Imam

Central Queensland Hospital and Health Service - Central Queensland Public Health Unit

Connie Slater

Central Queensland Hospital and Health Service - Central Queensland Public Health Unit

Robert Booy

Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS)

Gulam Khandaker

University of Queensland - School of Public Health

More...

Abstract

Background: Research on vaccine effectiveness is crucial to guide public health policy. In an Australian regional area, we evaluated vaccine effectiveness and waning immunity for the prevention of hospitalizations associated with SARS-CoV-2.

Methods: COVID-19 notification data between January-2022 and March-2022 for the Central Queensland region were linked to the Australian Immunization Register and hospital administration data. Vaccinated and unvaccinated cohorts were compared to estimate VE for their risk of hospitalization caused by the Omicron variants. VE was calculated after primary immunization with two doses of BNT162b2, ChAdOx1-nCoV-19, or mRNA-1273 vaccine and after a booster dose.

Findings: Out of 9,682 persons studied, 7,244 (75%) were vaccinated at the time of infection. Only 47 (0.5%) cases were hospitalized and 4 (0.04%) required ICU admission, with no deaths observed. VE for symptomatic hospital admission for persons with only a primary course (of either BNT162b2, ChAdOx1 or mRNA-1273) was 70.2% (95%CI 45.2, 84.4; p<0.001), and for persons with a booster was 82.1% (95%CI 48.3, 95.8; p=0.005). In First Nations population (n=665), VE for symptomatic hospital admission was 69.7% (95%CI -57.9, 95.8; p=0.172).

Interpretations: The symptomatic hospitalization rate for Omicron variant of SARS-CoV-2 was low. VE against symptomatic hospitalization in SARS-CoV-2 infections was high in persons with booster doses. Further work on understanding waning immunity is important for optimal booster dose scheduling.

Funding Information: This work was supported by the Royal Australasian College of Physicians 2023 Research Development Grant - 2023RDG00006, Moderna Global Fellowship 2022-01 and the Queensland Advancing Clinical Research Fellowship (PJ-70405-A034-X000-HE2993).

Declaration of Interests: All authors but NRS declare no conflict of interests. NRS was awarded the Moderna Global Fellowship 2022- 01.

Ethical Approval: This study was exempted from formal ethical review by the Townsville Hospital and Health Service Human Research Ethics Committee (HREC/82361).

Keywords: COVID-19, vaccine effectiveness, First Nations, case hospitalization rates, Omicron, public health, vaccine science, rural, regional, Australia

Suggested Citation

Smoll, Nicolas and Al Imam, Mahmudul and Slater, Connie and Booy, Robert and Khandaker, Gulam, The Effectiveness of COVID-19 Vaccination in a Regional Population. Available at SSRN: https://ssrn.com/abstract=4313555 or http://dx.doi.org/10.2139/ssrn.4313555

Nicolas Smoll (Contact Author)

Central Queensland Hospital and Health Service - Central Queensland Public Health Unit ( email )

Community Health Building
82-86 Bolsover Street
Rockhampton, Queensland 4700
Australia

Mahmudul Al Imam

Central Queensland Hospital and Health Service - Central Queensland Public Health Unit ( email )

Connie Slater

Central Queensland Hospital and Health Service - Central Queensland Public Health Unit ( email )

Community Health Building
82-86 Bolsover Street
Rockhampton, 4700
Australia

Robert Booy

Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS) ( email )

Gulam Khandaker

University of Queensland - School of Public Health ( email )

Queensland
Australia

Click here to go to TheLancet.com

Paper statistics

Downloads
87
Abstract Views
430
PlumX Metrics